# Effectiveness and Tolerability of Lidocaine 5% Spray in Treatment of Lifelong Premature Ejaculation Patients.

> **NCT04062357** · PHASE2 · COMPLETED · sponsor: **Sohag University** · enrollment: 150 (actual)

## Conditions studied

- Lidocaine Spray

## Interventions

- **DRUG:** Lidocaine 5% spray
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04062357
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-20
- **Primary completion:** 2019-01-20
- **Final completion:** 2019-04-20
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2019-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04062357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04062357, "Effectiveness and Tolerability of Lidocaine 5% Spray in Treatment of Lifelong Premature Ejaculation Patients.". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT04062357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*